Polo-like kinase 3 is required for entry into S phase

被引:81
|
作者
Zimmerman, Wendy C. [1 ]
Erikson, Raymond L. [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
关键词
Cdc25A; cyclin E; nucleolus;
D O I
10.1073/pnas.0610856104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The polo-like kinase, Plk1, which is expressed and active in mitosis, is involved in regulation of mitotic entry, spindle pole assembly, mitotic exit, and cytokinesis [Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM (2001) J Cell Sci 114:2357-2358]. In mammals, there are two other members of the polo-like kinase family that are less well understood, Plk2 and Plk3. Plk3 first was identif ied and cloned as an immediate early gene. Here, we report Plk3 localizes to the nucleolus and is involved in regulation of the G(1)/S phase transition. We demonstrate that the level of Plk3 protein is cell cycle regulated, peaking in G(1). We have delivered Plk3interfering RNA with lentivirus to serum-starved cells and found that, upon serum stimulation, Plk3 is required for cyclin E expression and entry into S phase. Plk3-interfering RNA-induced Plk3 depletion resulted in a large fraction of asynchronously proliferating cells to become quiescent. We propose the Plk3 requirement in the cell cycle is fulfilled in G1, and that once cells pass this point, they are able to complete cell division, whereas in the absence of Plk3, they fail to reenter the cell cycle. Additional data suggest that Plk3 may regulate entry into S phase in part through interaction with the phosphatase Cdc25A, because its depletion also resulted in attenuation of cyclin E expression.
引用
收藏
页码:1847 / 1852
页数:6
相关论文
共 50 条
  • [31] Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis
    Neef, R
    Preisinger, C
    Sutcliffe, J
    Kopajtich, R
    Nigg, EA
    Mayer, TU
    Barr, FA
    JOURNAL OF CELL BIOLOGY, 2003, 162 (05): : 863 - 875
  • [32] Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1
    Berg, Angela
    Berg, Thorsten
    CHEMBIOCHEM, 2016, 17 (08) : 650 - 656
  • [33] Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma
    Juntermanns, Benjamin
    Sydor, Svenja
    Kaiser, Gernot M.
    Jaradat, Derar
    Mertens, Joachim C.
    Sotiropoulos, Georgios C.
    Swoboda, Sandra
    Neuhaus, Jan P.
    Meng, Wei
    Mathe, Zoltan
    Baba, Hideo A.
    Canbay, Ali
    Paul, Andreas
    Fingas, Christian D.
    LIVER INTERNATIONAL, 2015, 35 (11) : 2448 - 2457
  • [34] Polo-like kinase in trypanosomes: an odd member out of the Polo family
    Kurasawa, Yasuhiro
    An, Tai
    Li, Ziyin
    OPEN BIOLOGY, 2020, 10 (10)
  • [35] Function and regulation of Polo-like Kinase 3 in human pancreatic cancer
    Li, Zhongkui
    Chang, Zhe
    Chiao, Paul J.
    CANCER RESEARCH, 2012, 72
  • [36] Polo-Like Kinase 3 is associated with improved Overall Survival in Cholangiocarcinoma
    Juntermanns, Benjamin
    Sydor, Svenja
    Kaiser, Gernot M.
    Paul, Andreas
    Baba, Hideo A.
    Canbay, Ali
    Fingas, Christian Dominik
    HEPATOLOGY, 2014, 60 : 647A - 648A
  • [37] Function and Regulation of Polo-Like Kinase 3 in Human Pancreatic Cancer
    Li, Z.
    Chang, Z.
    Chiao, P. J.
    PANCREAS, 2011, 40 (08) : 1334 - 1334
  • [38] Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells
    Pezuk, Julia Alejandra
    Brassesco, Maria Sol
    Manzini Ramos, Priscila Maria
    Scrideli, Carlos Alberto
    Tone, Luiz Gonzaga
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (09) : 1278 - 1291
  • [39] The polo-like kinase 1 regulates CDC25B-dependent mitosis entry
    Lobjois, Valerie
    Jullien, Denis
    Bouche, Jean-Pierre
    Ducommun, Bernard
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (03): : 462 - 468
  • [40] AURORA AND POLO-LIKE KINASE INHIBITORS: A CLINICAL PERSPECTIVE
    Awada, A.
    Metzger, O.
    ANNALS OF ONCOLOGY, 2010, 21 : 27 - 27